CA2441096A1 - Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques - Google Patents
Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques Download PDFInfo
- Publication number
- CA2441096A1 CA2441096A1 CA002441096A CA2441096A CA2441096A1 CA 2441096 A1 CA2441096 A1 CA 2441096A1 CA 002441096 A CA002441096 A CA 002441096A CA 2441096 A CA2441096 A CA 2441096A CA 2441096 A1 CA2441096 A1 CA 2441096A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor agonists
- inflammatory diseases
- agonists
- treatment
- nicotinic receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 abstract 3
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 abstract 3
- 208000029523 Interstitial Lung disease Diseases 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 2
- 208000023367 bronchiolitis obliterans with obstructive pulmonary disease Diseases 0.000 abstract 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 206010029888 Obliterative bronchiolitis Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 206010035742 Pneumonitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000003848 bronchiolitis obliterans Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 abstract 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 201000000306 sarcoidosis Diseases 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002441096A CA2441096C (fr) | 2001-03-23 | 2002-03-25 | Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques |
| US13/178,670 US8551983B2 (en) | 2002-03-25 | 2011-07-08 | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US13/190,941 US8557804B2 (en) | 2002-03-25 | 2011-07-26 | Nicotinic receptor agonists for the treatment of inflammatory diseases |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,341,952 | 2001-03-23 | ||
| CA002341952A CA2341952A1 (fr) | 2001-03-23 | 2001-03-23 | Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires |
| CA002441096A CA2441096C (fr) | 2001-03-23 | 2002-03-25 | Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques |
| PCT/CA2002/000412 WO2002076434A2 (fr) | 2001-03-23 | 2002-03-25 | Traitement d'affections inflammatoires au moyen d'agonistes des récepteurs nicotiniques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2441096A1 true CA2441096A1 (fr) | 2002-10-03 |
| CA2441096C CA2441096C (fr) | 2009-06-30 |
Family
ID=29585104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002441096A Expired - Fee Related CA2441096C (fr) | 2001-03-23 | 2002-03-25 | Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2441096C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006005195A1 (fr) * | 2004-07-15 | 2006-01-19 | UNIVERSITé LAVAL | Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires |
-
2002
- 2002-03-25 CA CA002441096A patent/CA2441096C/fr not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006005195A1 (fr) * | 2004-07-15 | 2006-01-19 | UNIVERSITé LAVAL | Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires |
| KR100860903B1 (ko) * | 2004-07-15 | 2008-09-29 | 유니버시티 라발 | 염증성 질환 치료용 니코틴성 수용체 효능제 |
| AU2005262174B2 (en) * | 2004-07-15 | 2009-10-08 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| AU2005262174C1 (en) * | 2004-07-15 | 2010-05-06 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| CN101001843B (zh) * | 2004-07-15 | 2014-08-27 | 拉瓦尔大学 | 用于治疗炎性疾病的烟碱受体激动剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2441096C (fr) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157757A0 (en) | Nicotine receptor agonists for the treatment of inflammatory diseases | |
| WO2004058769A3 (fr) | Compositions utiles en tant qu'inhibiteurs des proteine kinases | |
| WO2005039485A3 (fr) | Inhibiteurs de gsk-3 et utilisations | |
| WO2005073224A3 (fr) | Composes et methodes d'utilisation de ces derniers | |
| WO2007117715A3 (fr) | Modulateurs des transporteurs de cassettes de liaison de l'atp | |
| WO2006138010A3 (fr) | Implant tissulaire articule et procedes et dispositifs correspondants destines a la mise en place d'un tel implant | |
| WO2005105780A3 (fr) | Compositions utiles en tant qu'inhibiteurs de la rock et d'autres proteines kinases | |
| WO2007002635A3 (fr) | Antagonistes cycliques a liaison c du recepteur p2y1, utiles pour traiter des etats pathologiques thrombotiques | |
| IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
| BE2013C023I2 (fr) | ||
| CA2389349A1 (fr) | Utilisation de composes organiques dans le traitement d'une maladie | |
| WO2005028475A3 (fr) | Compositions utiles pour inhiber des proteines kinases | |
| WO2008011559A3 (fr) | Tensioactif pulmonaire synthetique et utilisation associée | |
| EP1251126A3 (fr) | Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation | |
| WO2004103296A3 (fr) | Methodes de traitement d'une fibrose pulmonaire idiopathique | |
| NO20074084L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse | |
| CA2461517A1 (fr) | Preparations de nicotine comprenant du cacao, et utilisation | |
| WO2006045314A3 (fr) | Utilisation d'un secretagogue de l'hormone de croissance en vue d'accroitre ou de maintenir la masse maigre et/ou pour le traitement de la maladie pulmonaire obstructive chronique | |
| ZA202201827B (en) | Therapeutic fusion proteins | |
| EP1348466A3 (fr) | Méthode de traitement du douleur avec adenosine tetraphosphates | |
| WO2007075572A3 (fr) | Inhibiteurs a base de purine oralement actifs de la proteine de choc thermique 90 | |
| WO2022240379A3 (fr) | Composition pharmaceutique stable comprenant du sélexipag | |
| WO2002072571A3 (fr) | Pyridinyl-pyrazoles utiles pour le traitement de la bronchopneumopathie chronique obstructive | |
| WO2005051931A3 (fr) | Inhibiteurs de la phosphodiestérase | |
| CA2441096A1 (fr) | Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20160329 |